SERUM-CALCIUM AND MAGNESIUM IN SCHIZOPHRENIA - RELATIONSHIP TO CLINICAL PHENOMENA AND NEUROLEPTIC TREATMENT

被引:36
作者
ALEXANDER, PE
VANKAMMEN, DP
BUNNEY, WE
机构
[1] VET ADM HOSP, PROVIDENCE, RI 02908 USA
[2] NIMH, BIOL PSYCHIAT BRANCH, NEUROPSYCHOPHARMACOL UNIT, BETHESDA, MD 20014 USA
关键词
D O I
10.1192/bjp.133.2.143
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:143 / 149
页数:7
相关论文
共 48 条
[1]  
ALEXANDER PE, UNPUBLISHED
[2]   RECEPTOR ACTIVITY AND TURNOVER OF DOPAMINE AND NORADRENALINE AFTER NEUROLEPTICS [J].
ANDEN, NE ;
BUTCHER, SG ;
CORRODI, H ;
FUXE, K ;
UNGERSTEDT, U .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 11 (03) :303-+
[3]   ELECTROLYTES IN BLOOD IN ENDOGENOUS DEPRESSION [J].
BJORUM, N .
ACTA PSYCHIATRICA SCANDINAVICA, 1972, 48 (01) :59-&
[4]   RELATION OF HYPERMAGNESAEMIA TO ACTIVITY AND NEUROLEPTIC DRUG THERAPY IN SCHIZOPHRENIC STATES [J].
BRACKENRIDGE, CJ ;
JONES, IH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1971, 34 (02) :195-+
[5]  
BUNNEY WE, 1963, ARCH GEN PSYCHIAT, V9, P280
[6]  
CADE J F, 1964, Med J Aust, V1, P195
[7]  
CARMAN JS, 1977, BIOL PSYCHIAT, V12, P5
[8]  
CARMAN JS, 1977, NEUROREGULATORS PSYC
[9]  
CARMAN JS, 1977, COMMUNICATION
[10]  
CARMAN JS, UNPUBLISHED